TOKY, Japan and REDWOOD CITY, California– Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announce that the United States Food and Drug…
Zurich-Schlieren, SWITZERLAND—Molecular Partners AG (SIX: MOLN), a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies*, today announced that its Board…
NEWARK, California—Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions, today announced that Mark Foley…
Pleasanton, California – – IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The…
PLYMOUTH, Minnesota—Entellus Medical, Inc. (NASDAQ: ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive…
NEWARK, Calif.——Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions, today announced duration of effect…
The Wall Street Journal - Opinion/Commentary
By Regina Benjamin and Adnrew Theompson
Mobile phones and tablets have pushed themselves to the center of modern life.…
PLYMOUTH, MN and CHICAGO, IL—Entellus Medical, Inc. (NASDAQ: ENTL) announced today that Dr. Zachary M. Soler, MD, MSc, Medical University of South Carolina, presented the…